Remdesivir Treatment in Moderately Ill COVID-19 Patients: A Retrospective Single Center Study

Almost two years after remdesivir was approved and extensively used in numerous clinical studies for the treatment of COVID-19 patients, there is still no clear recommendation for the time and phase of the disease of remdesivir administration. This retrospective observational study included adults (...

Descripción completa

Detalles Bibliográficos
Autores principales: Terkes, Vedrana, Lisica, Karla, Marusic, Martina, Verunica, Nikola, Tolic, Anela, Morovic, Miro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457067/
https://www.ncbi.nlm.nih.gov/pubmed/36078997
http://dx.doi.org/10.3390/jcm11175066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457067/
https://www.ncbi.nlm.nih.gov/pubmed/36078997
http://dx.doi.org/10.3390/jcm11175066

Ejemplares similares